These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17984453)

  • 1. Vascular factors predict rate of progression in Alzheimer disease.
    Mielke MM; Rosenberg PB; Tschanz J; Cook L; Corcoran C; Hayden KM; Norton M; Rabins PV; Green RC; Welsh-Bohmer KA; Breitner JC; Munger R; Lyketsos CG
    Neurology; 2007 Nov; 69(19):1850-8. PubMed ID: 17984453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.
    Rosenberg PB; Mielke MM; Tschanz J; Cook L; Corcoran C; Hayden KM; Norton M; Rabins PV; Green RC; Welsh-Bohmer KA; Breitner JC; Munger R; Lyketsos CG
    Am J Geriatr Psychiatry; 2008 Nov; 16(11):883-92. PubMed ID: 18978249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease.
    Mielke MM; Leoutsakos JM; Tschanz JT; Green RC; Tripodis Y; Corcoran CD; Norton MC; Lyketsos CG
    J Alzheimers Dis; 2011; 26(1):127-34. PubMed ID: 21593560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
    Steinberg M; Hess K; Corcoran C; Mielke MM; Norton M; Breitner J; Green R; Leoutsakos J; Welsh-Bohmer K; Lyketsos C; Tschanz J
    Int J Geriatr Psychiatry; 2014 Feb; 29(2):153-9. PubMed ID: 23681754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    Sanders C; Behrens S; Schwartz S; Wengreen H; Corcoran CD; Lyketsos CG; Tschanz JT
    J Alzheimers Dis; 2016 Feb; 52(1):33-42. PubMed ID: 26967207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.
    Tschanz JT; Corcoran CD; Schwartz S; Treiber K; Green RC; Norton MC; Mielke MM; Piercy K; Steinberg M; Rabins PV; Leoutsakos JM; Welsh-Bohmer KA; Breitner JC; Lyketsos CG
    Am J Geriatr Psychiatry; 2011 Jun; 19(6):532-42. PubMed ID: 21606896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes.
    Haaksma ML; Calderón-Larrañaga A; Olde Rikkert MGM; Melis RJF; Leoutsakos JS
    Int J Geriatr Psychiatry; 2018 Aug; 33(8):1057-1064. PubMed ID: 29761569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.
    Leoutsakos JM; Han D; Mielke MM; Forrester SN; Tschanz JT; Corcoran CD; Green RC; Norton MC; Welsh-Bohmer KA; Lyketsos CG
    Int Psychogeriatr; 2012 Oct; 24(10):1561-70. PubMed ID: 22687143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes.
    Irimata KE; Dugger BN; Wilson JR
    Curr Alzheimer Res; 2018; 15(11):1032-1044. PubMed ID: 29962344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.
    Bleckwenn M; Kleineidam L; Wagner M; Jessen F; Weyerer S; Werle J; Wiese B; Lühmann D; Posselt T; König HH; Brettschneider C; Mösch E; Weeg D; Fuchs A; Pentzek M; Luck T; Riedel-Heller SG; Maier W; Scherer M
    Br J Gen Pract; 2017 Feb; 67(655):e111-e117. PubMed ID: 27993897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study.
    Gabin JM; Tambs K; Saltvedt I; Sund E; Holmen J
    Alzheimers Res Ther; 2017 May; 9(1):37. PubMed ID: 28569205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.
    Lee WJ; Liao YC; Wang YF; Lin YS; Wang SJ; Fuh JL
    J Am Geriatr Soc; 2020 Jan; 68(1):129-136. PubMed ID: 31587263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
    J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.
    Musicco M; Palmer K; Salamone G; Lupo F; Perri R; Mosti S; Spalletta G; di Iulio F; Pettenati C; Cravello L; Caltagirone C
    J Neurol; 2009 Aug; 256(8):1288-95. PubMed ID: 19353221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of vascular risk factors and risk of incident Alzheimer disease.
    Luchsinger JA; Reitz C; Honig LS; Tang MX; Shea S; Mayeux R
    Neurology; 2005 Aug; 65(4):545-51. PubMed ID: 16116114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.